A Study of ATG-201 in Adult Participants With Autoimmune Diseases

Clinical trial NCT07732309 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07732309
Sponsor: Antengene Biologics Limited
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Systemic Sclerosis (SSc)Sjogren's Disease

Start date: 2026-09-01
Primary completion: 2028-12-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.